1. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. (23rd January 2019) Authors: Delaloge, S; Cella, D; Ye, Y; Buyse, M; Chan, A; Barrios, C H; Holmes, F A; Mansi, J; Iwata, H; Ejlertsen, B; Moy, B; Chia, S K L; Gnant, M; Smichkoska, S; Ciceniene, A; Martinez, N; Filipović, S; Ben-Baruch, N E; Joy, A A; Langkjer, S T Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗